TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
6.93
+0.29 (4.37%)
Dec 31, 2025, 12:44 PM EST - Market open
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $346.25 million as of December 31, 2025. Its market cap has increased by 186.02% in one year.
Market Cap
346.25M
Enterprise Value
343.20M
1-Year Change
186.02%
Ranking
Category
Stock Price
$6.93
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has increased from $328.75M to $346.25M, an increase of 5.32%. That is a compound annual growth rate of 1.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 331.76M | 117.16% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
| Feb 8, 2021 | 328.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.87B |
| Johnson & Johnson | 500.07B |
| AbbVie | 407.98B |
| UnitedHealth Group | 297.97B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 264.63B |
| Novo Nordisk | 229.27B |